LBBW Venture Capital invests in early-stage disruptive IT and life science companies in the DACH region. It aims to participate in early-stage financings from Seed to Series A with initial ticket sizes of up to €3m.
peer of
invested in
competitor of
Metrics
marketPRIVATE
msh_idDE:LBBWVC
localede
websitehttps://www.lbbwvc.de/
source_ref6144ebbc-50de-49ee-9acd-ca32025f1867
products_or_servicesInvestment in early-stage disruptive IT and life science companies, including software driven approaches, drug development, diagnostics, and medical devices.
Germany